BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1379117)

  • 21. [Experimental research to clinical application of interferons].
    Imamishi J; Tanaka A
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.
    Bukowski RM
    Semin Oncol; 2000 Apr; 27(2):204-12. PubMed ID: 10768599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alfa interferon: combinations with other antineoplastic modalities.
    Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of metastatic renal cell carcinoma.
    Reeves DJ; Liu CY
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon in metastatic renal cell carcinoma.
    Fosså SD
    Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the treatment of urothelial tract tumors.
    Sternberg CN; Scher HI
    Urol Clin North Am; 1987 May; 14(2):373-87. PubMed ID: 3554694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K; Tsukamoto T
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
    Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL
    Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of interferons in the treatment of hematologic malignancies.
    Gutterman JU
    Semin Hematol; 1988 Jul; 25(3 Suppl 3):3-8. PubMed ID: 2459780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors.
    Clark JR; Fallon BG; Frei E
    Important Adv Oncol; 1987; ():175-95. PubMed ID: 3331380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of IL-2.
    Sznol M; Parkinson DR
    Oncology (Williston Park); 1994 Jun; 8(6):61-7; discussion 67, 71, 74-5. PubMed ID: 7521197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T; Marumo K
    Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukemia: A model for drug development.
    Keating MJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineoplastic activity of the combination of 5-fluorouracil and interferon: preclinical and clinical results.
    Wadler S
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):38-40. PubMed ID: 1372764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma: therapeutic options with recombinant interferons.
    Kirkwood JM; Ernstoff M
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):7-12. PubMed ID: 2417333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).
    Toma S; Ugolini D; Palumbo R
    Int J Oncol; 1999 Aug; 15(2):321-37. PubMed ID: 10402244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors.
    Dal Lago L; D'Hondt V; Awada A
    Oncologist; 2008 Aug; 13(8):845-58. PubMed ID: 18695262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.